Teva Pharmaceutical's total assets for Q3 2024 were $41.76B, an increase of 1.02% from the previous quarter. DE:TEV total liabilities were $35.38B for the fiscal quarter, a 13.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.